Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumorigenesis
52%
Tumor Cells
47%
Tumor Regression
46%
Tumor
40%
Oncogene
37%
Chemotherapy Resistance
36%
MTOR Pathway
36%
Chemosensitivity
36%
MYC Oncogene
36%
Mammalian Target of Rapamycin (mTOR)
33%
Apoptosis
32%
XPO1
32%
Cellular Senescence
31%
Oncogene Inactivation
30%
Non-oncogene Addiction
28%
Human Cancer
28%
Proliferative Arrest
26%
Addiction
24%
MTOR Inhibitor
24%
Persisters
24%
Immune System
24%
Double-hit Lymphoma
24%
Endoplasmic Reticulum
24%
Senescence
23%
Tumor Microenvironment
23%
Overexpression
22%
Cancer Cells
21%
Pancreatic Cancer Cells
21%
Residual Tumor
21%
Cell Proliferation
19%
Angiogenesis
19%
Driver Oncogene
18%
Cancer Therapeutics
18%
Library Screen
18%
Tumor Recurrence
17%
MiR-17-92
16%
Nucleocytoplasmic Transport
16%
Checkpoint Mechanisms
16%
XPO1 Inhibitor
15%
EIF2α Kinase
15%
Mouse Model
14%
Computational Approach
14%
In Cancer
14%
Transgenic Mouse Model
14%
Host Immune Response
13%
Targeted Therapeutics
13%
Induced Apoptosis
13%
Immune Response
12%
Gene-deficient Mice
12%
Selective Labeling
12%
Biochemistry, Genetics and Molecular Biology
Oncogene
100%
Programmed Cell Death
58%
Carcinogenesis
44%
Chemosensitivity
36%
Mammalian Target of Rapamycin
36%
Genetics
27%
Cancer Cell
27%
Immune Response
27%
Angiogenesis
25%
Mouse Model
25%
Phosphotransferase
24%
Kinase
24%
Cell Proliferation
24%
Tumor Progression
21%
XPO1
20%
Drive
18%
Genetic Mechanism
16%
Protein Biosynthesis
15%
Proinsulin
15%
Transgenic Mouse
14%
Maturation
12%
Disulfide
12%
Proteome
12%
DNA Transcription
12%
Epigenetics
12%
Catenin
12%
Nuclear Transport
12%
Cell Metabolism
12%
Cell Fate
12%
EIF2AK3
12%
DNA Synthesis
12%
Cell Growth
12%
Thiosalicylic Acid
12%
Endoplasmic Reticulum Stress
12%
Proto Oncogene
12%
Cellular Differentiation
12%
Glucose Homeostasis
12%
Endoplasmic-Reticulum-Associated Protein Degradation
12%
Metabolic Pathway
12%
Glutamine
12%
Insulin-Like Growth Factor 1
12%
Immunocompetent Cell
9%
ATF4
8%
Deficiency
8%
Cell Survival
7%
Newborn Period
6%
Transgenics
6%
CRISPR
6%
MicroRNA
6%
Secretion (Process)
5%
Medicine and Dentistry
Oncogene
56%
Carcinogenesis
40%
Tumor
35%
Tumor Regression
32%
Malignant Neoplasm
32%
Tumor Cell
30%
Programmed Cell Death
24%
Cell Differentiation
21%
Cell Proliferation
19%
Cancer
18%
Cellular Senescence
17%
Angiogenesis
16%
Immune Response
16%
Tumor Microenvironment
16%
Catenin
12%
Cancer Regression
12%
Addictive Behavior
12%
Endonuclease
12%
Diabetes
12%
Glucose Homeostasis
12%
Cre Recombinase
12%
Nuclear Export
12%
Tamoxifen
12%
Cancer Therapy
12%
Acinar Cell
12%
Exocrine Pancreas
12%
Effective Treatment
12%
Differentiation Therapy
12%
Immune System
12%
Chemosensitivity
12%
Mammalian Target of Rapamycin
12%
Maturation
12%
Initiation Factor 2
12%
Acute Myeloid Leukemia
12%
Phosphotransferase
12%
Mebendazole
12%
Protein Synthesis
10%
Tumor Progression
9%
Endoplasmic Reticulum Stress
9%
Receptor
8%
Proto Oncogene
7%
DNA Transcription
7%
Cell Metabolism
7%
Cell Growth
7%
DNA Synthesis
7%
Cell Fate
7%
Clinical Trial
6%
Homeostasis
6%
Leukemia
6%
Immunocompetent Cell
5%